Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load | MicrobiomeTrials← Back to trialsNCT05968846
Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2022-12-07Est. Completion: 2023-08-01
Enrollment target: 19 participants Locations- University of Tennessee Graduate School of Medicine, Knoxville, Tennessee, United States
Other microbiome trials you might be interested in
Hereditary Corneal DystrophyCorneal AbnormalityCorneal DystrophiesCorneal Dystrophies, Hereditary
The goal of this clinical trial is to evaluate the safety and efficacy of GEB-101 injection in subjects with TGFBI-relat…
Los Angeles, United StatesEst. completion Aug 2027
Metabolic Syndrome
This randomized, double-blind, placebo-controlled, parallel-group study evaluated the effects of six-month oral suppleme…
Wroclaw, PolandCompleted Jun 25, 2026